跳至主要内容
临床试验/NCT02463357
NCT02463357已完成4 期

Three New Ideas to Protect Special Forces From the Stress of High Altitude

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
148
试验地点
1
主要终点
Change in Uphill Hike at High Altitude

研究概览

简要总结

Acute Mountain Sickness (AMS) is a well-documented syndrome that affects 42% of non-acclimatized individuals traveling to altitudes above 10,000 feet. Decreased barometric pressure, which leads to low blood oxygen levels, is the primary casual factor of AMS. Symptoms of AMS are characterized by headache, nausea, vomiting, dizziness, fatigue and difficultly sleeping. Moreover, when people travel to high altitude, cognitive performance and endurance exercise capacity are impaired. Therefore, the goal of this research is to identify effective pharmacological agents that will help reduce the symptoms of AMS and improve physical and cognitive performance at high altitude.

The investigators will study the efficacy of the dietary supplement, quercetin, the drugs nifedipine (extended release) and methazolamide taken together, the drug metformin, and the drug nitrite in reducing symptoms of AMS and improving cognitive and exercise performance at high altitudes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • young (18-30 years old) men who can meet APFT requirements for special operation forces (SOF) training as outlined by the US Army (42 push ups, 53 sit-ups, 6 pull-ups, 2 mile run in < 15 min 54 s)

排除标准

  • participants with diseases or disorders known to be affected by hypoxia or the drugs used in this study, such as hypotension, anemia, sickle cell trait or disease, and diabetes;
  • participants with a history of significant head injury, migraines or seizures;
  • participants taking any medication (over-the-counter or prescription) or herbal supplements;
  • participants with known flavonoid allergies;
  • participants with known allergies to metformin;
  • participants with known hypersensitivity reaction to nifedipine;
  • participants with known allergies to sulfonamide-based drugs;
  • participants with inability to be headache-free when consuming the amount of caffeine in two six ounce cups of coffee or less per day;
  • exposure to high altitude above 1000m in the previous three months; or
  • participants who have been on an airline flight over six hours (the lowered cabin pressure for an extended period of time approximates exposure to high altitude);
  • participants who are unable to achieve the minimum physical criteria required for SOF training

研究组 & 干预措施

Quercetin

Experimental

Quercetin: 500mg pill, twice daily for 5 days

干预措施: Quercetin (Dietary Supplement)

Nifedipine+Methazolamide

Experimental

Nifedipine extended release: 30mg pill, twice daily for 5 days; Methazolamide: 125mg pill, twice daily for 5 days

干预措施: Nifedipine extended release (Drug)

Nifedipine+Methazolamide

Experimental

Nifedipine extended release: 30mg pill, twice daily for 5 days; Methazolamide: 125mg pill, twice daily for 5 days

干预措施: Methazolamide (Drug)

Metformin

Experimental

Metformin: 500mg pill, once daily for 2 days, then 500mg twice daily at altitude (3 days)

干预措施: Metformin (Drug)

Placebo

Placebo Comparator

Sugar pill manufactured to look like all other investigational products

干预措施: Placebo (Drug)

Nitrite

Experimental

Nitrite: 20mg pill, three times daily for 5 days

干预措施: Nitrite (Drug)

结局指标

主要结局

Change in Uphill Hike at High Altitude

时间窗: 2nd day at altitude

Timed 3.1 mile uphill run/hike, with weighted back-pack

Change in Environmental Symptoms Questionnaire at High Altitude

时间窗: Baseline and during high altitude exposure (3 days, AM/PM)

Self-reported assessment of AMS symptoms (headache, lightheaded, dizzy, etc.). The 11-item Environmental Symptoms Questionnaire measures Acute Mountain Sickness symptoms (nausea, weakness, lightheadedness, dizziness, headache, etc.). Possible scores range from 0 to 55 (0-5 per item), with higher scores indicating a better outcome.

Change in Lake Louise AMS Scoring System at High Altitude

时间窗: Baseline and during high altitude exposure (3 days, AM/PM)

Self-reported assessment of AMS symptoms (headache, nausea, vomiting, dizziness, fatigue and difficultly sleeping). The Lake Louise AMS Scoring System measures symptoms of altitude sickness. Possible scores range from 0 to 16, with higher scores indicating a worse outcome.

Change in Army Physical Fitness Test (APFT) at High Altitude

时间窗: Baseline, 1st day at high altitude

Timed 2 mile run, push-ups, sit-ups, and pull-ups. The Army Physical Fitness Test (APFT) measures physical fitness. Higher scores indicate a better outcome. A score of 60 is considered minimum "passing" score. The maximum possible score is 300, indicating the highest level of physical fitness.

Change in Defense Automated Neurobehavioral Assessment (DANA) Reaction Time at High Altitude

时间窗: Baseline and and 1st day at high altitude

Battery of nine cognitive function tests. The Defense Automated Neurobehavioral Assessment (DANA) measures cognitive function and was used to measure mean reaction time. Possible scores range from 180 to 500 milliseconds, with lower scores indicating a better outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验